BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 20, 2005
View Archived Issues
It's Official: Inex's Marqibo Gets Not-Approvable Letter From FDA
As expected, the FDA turned down Inex Pharmaceuticals Corp.'s Marqibo (vincristine sulfate liposomes injection). (BioWorld Today)
Read More
Synta Files For $115M IPO; Proceeds To Push Pipeline
Read More
AVI Sky High On Patents, Potential For State Funds
Read More
Neoprobe Forms Subsidiary As Home For ACT Platform
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More